Eurepa-V 1/0.3 Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Repaglinide (1mg) + Voglibose (0.3mg)
Overview Eurepa-V 1/0.3 Tablet
DiabetaComb 1/0.3 tablets combine two medications to manage type 2 diabetes. This treatment helps regulate post-meal blood glucose. It's prescribed when dietary changes and other similar drugs prove insufficient to control elevated blood sugar. DiabetaComb 1/0.3 should be taken immediately following meals; dosage is determined by your physician. Discontinuing the medication without consulting your doctor can lead to dangerously high blood sugar, potentially causing severe complications such as kidney disease and vision loss. For missed doses, avoid taking it between meals; administer with your next meal as usual. Never double the dose. This medication is part of a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor. Common, usually transient, side effects include gas, diarrhea, abdominal discomfort, hypoglycemia, and skin rashes. Persistent side effects warrant medical attention. Regular blood glucose monitoring is essential. Inform your doctor of any kidney, liver, or urinary tract issues, diuretic use, or pregnancy/breastfeeding before starting treatment. Limit alcohol consumption, as it may increase the risk of adverse effects.
Primary Ingredients of Eurepa-V 1/0.3 Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Eurepa-V 1/0.3 Tablet
Managing type 2 diabetes
Major Benefits of Eurepa-V 1/0.3 Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Eurepa-V 1/0.3 Tablet with a meal.
Common Side effects of Eurepa-V 1/0.3 Tablet:
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Diarrhea
- Flatulence
- Headache
How to use Eurepa-V 1/0.3 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; do not chew, crush, or fracture it. Consume Eurepa-V 1/0.3 Tablet with food.
How Eurepa-V 1/0.3 Tablet works:
One tablet of Eurepa-V 1/0.3 contains a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Eurepa-V 1/0.3 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Eurepa-V 1/0.3 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against the risks before prescribing this medication. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Administration of Eurepa-V 1/0.3 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with excessively high or low blood sugar levels. Refrain from driving if such symptoms manifest.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Eurepa-V 1/0.3 Tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Eurepa-V 1/0.3 Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Eurepa-V 1/0.3 Tablet :
Should you forget a Eurepa-V 1/0.3 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Eurepa-V 1/0.3 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently
